Baden-Baden (ots) - Bei der diesjährigen ordentlichen Hauptversammlung der Aktionäre der Schöck AG am 24. ...
FORA® Diamond GD50 Blood Glucose Monitoring Device Used in United4Health European Project via Diabtel.net
Project Aims to Demonstrate Value of Remote Monitoring for Management of Chronic Diseases
St. Gallen (ots) - ForaCare Suisse AG located in St. Gallen, Switzerland, announced today its Diamond GD50 health monitoring device is featured in the "United4Health European Project" via its partnership with Meter Ltd., FORA's Italian distributor.
The United4Health European Project aims to demonstrate the value of remote monitoring services for the management of chronic diseases such as congestive heart failure, diabetes, and chronic obstructive pulmonary disease.
Meter's Diabtel.net is a free telemonitoring system that provides a platform for self-monitoring tools such as ForaCare's blood pressure and blood glucose monitoring devices and system.
Diabtel.net provides infrastructure for the telehealth project's work, which featured the FORA® Diamond GD50 blood glucose monitoring device, in Italy that was developed in two regions: Campania and Calabria. Diabtel.net managed blood glucose monitoring in Campania. The Campania project, which began in April 2015, includes 120 insulin-treated patients who are monitored with four measurements per day over 12 months.
"We are pleased to see the great work Meter is doing in the telehealth space and that our GD50 blood glucose monitor is featured in this important project," said Ty-Minh Tan, CEO of ForaCare Suisse AG.
"The program's goal is to implement telehealth into the care of patients living with Type 2 diabetes," said Antonio De Falco, Meter's area manager. "By doing so, we can support and improve self-management to help reduce exacerbations and the development of diabetes related complications."
Coverage of Diabtelnet can be found at:
All ForaCare monitoring devices are validated as highly accurate in the industry and provide superior quality directly to consumers. FORA® Blood Glucose Monitors are validated according to ISO 15197 requirements at an internationally renowned diabetes institute in Ulm, Germany.
FDA cleared and CE marked innovative health monitoring devices that provide simple connection to the FORA system. For more information, please visit http://www.foracare.ch/
About ForaCare Suisse AG: http://www.foracare.ch/
Elena BirrerOriginal-Content von: ForaCare Suisse AG, übermittelt durch news aktuell